Cancer Family
Skin Epithelial Neoplasm
CI-CAN-00000350Explore in graph →
Non-malignant138 active trials2 approved drugs4 evidence items
- NCIt
- C7342
Loading cancer entity…
Cancer Family
CI-CAN-00000350Explore in graph →
Clinical trials
451 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03894618 | SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 49 | Shattuck Labs, Inc.INDUSTRY | 4 | Apr 2, 2025 | clinicaltrials |
| NCT06894056 | Investigating the Effects of Orienting Skin Grafts Parallel to Skin Tension Lines on Quality of Life in Head and Neck Located Basal Cell Carcinoma | completed | — | 71 | Sifa Okulu - Independent Research Center of Dermatology and VenereologyOTHER | 1 | Mar 25, 2025 |
| clinicaltrials |
| NCT06214559 | Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts. | completed | N/A | 33 | Swiss Footcare Laboratories - Poderm ProfessionalINDUSTRY | 1 | Mar 5, 2025 | clinicaltrials |
| NCT00604890 | Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma | completed | Phase 1 / Phase 2 | 186 | BPGbioINDUSTRY | 1 | Feb 28, 2025 | clinicaltrials |
| NCT03024866 | Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study. | completed | — | 369 | Xoft, Inc.INDUSTRY | 1 | Feb 6, 2025 | clinicaltrials |
| NCT04710498 | Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma | completed | Phase 2 | 20 | Stanford UniversityOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT04969419 | Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo | completed | — | 75,771 | Momentum DataINDUSTRY | 1 | Jan 14, 2025 | clinicaltrials |
| NCT05257486 | Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx | completed | — | 183 | Xoft, Inc.INDUSTRY | 1 | Jan 13, 2025 | clinicaltrials |
| NCT00715819 | Use of Otoscope as a Non-invasive Tool for Diagnosis of Pilomatricoma | completed | — | 4 | Stanford UniversityOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT04470726 | Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype(NMSC) | completed | Phase 1 / Phase 2 | 26 | AiViva BioPharma, Inc.INDUSTRY | 1 | Dec 27, 2024 | clinicaltrials |
| NCT03487549 | Cantharidin and Occlusion in Verruca Epithelium(COVE-1) | completed | Phase 2 | 56 | Verrica Pharmaceuticals Inc.INDUSTRY | 1 | Nov 27, 2024 | clinicaltrials |
| NCT04870840 | Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer | completed | Phase 1 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT05896215 | OM202JP Clinical Study of KNP2002 | completed | Phase 2 | 159 | KinoPharma Inc.INDUSTRY | 1 | Sep 27, 2024 | clinicaltrials |
| NCT04160065 | Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers | completed | Phase 1 | 23 | TuHURA Biosciences, Inc.INDUSTRY | 1 | Sep 23, 2024 | clinicaltrials |
| NCT04334824 | Hydrochlorothiazide and Risk of Skin Cancer | completed | — | 2,953,748 | Canadian Network for Observational Drug Effect Studies, CNODESOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT00655655 | Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 96 | Mayo ClinicOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT00469417 | Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma | completed | Phase 3 | 120 | Galderma R&DINDUSTRY | 7 | Aug 19, 2024 | clinicaltrials |
| NCT04925713 | IFx-Hu2.0 for the Treatment of Patients With Skin Cancer | completed | Phase 1 | 5 | TuHURA Biosciences, Inc.INDUSTRY | 1 | Aug 2, 2024 | clinicaltrials |
| NCT05713760 | Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults | completed | Phase 2 | 5 | Austin Institute for Clinical ResearchNETWORK | 1 | Jul 19, 2024 | clinicaltrials |
| NCT02964559 | Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer | completed | Phase 2 | 11 | Emory UniversityOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06046144 | Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors(Micro3) | completed | — | 161 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT04229277 | Fast Track Diagnosis of Skin Cancer by Advanced Imaging | completed | N/A | 41 | University Hospital Bispebjerg and FrederiksbergOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT05877313 | Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts) | completed | Phase 2 | 20 | Sanotize Research and Development corp.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05070754 | Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca | completed | Phase 4 | 17 | Medical University of South CarolinaOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT03590054 | Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies | completed | Phase 1 | 35 | Rahul AggarwalOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT03110159 | DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients | completed | Phase 1 / Phase 2 | 8 | Medical Dermatology SpecialistsOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT03246412 | Nevus Doctor Clinical Decision Support for GPs | completed | N/A | 35 | University Hospital of North NorwayOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT02324608 | Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer | completed | N/A | 15 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT04793529 | Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study | completed | N/A | 60 | Benha UniversityOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT04456140 | Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study | completed | Phase 1 | 230 | Mayo ClinicOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05493826 | Real World Study on the Use of Cemiplimab in Adult Patients in UK(REACT-CEMI) | completed | — | 110 | SanofiINDUSTRY | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05842421 | Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors | completed | N/A | 250 | Technische Universität DresdenOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT00392561 | Bangladesh Vitamin E and Selenium Trial(BEST) | completed | N/A | 7,000 | University of ChicagoOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT01662713 | Optical Frequency Domain Imaging for Non-melanoma Skin Cancers(OFDI) | completed | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 15, 2023 | clinicaltrials |
| NCT05115669 | Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts | completed | N/A | 50 | Karo Pharma ABINDUSTRY | 1 | Feb 21, 2023 | clinicaltrials |
| NCT04932746 | The Effect of Dexmedetomidine on Oxygen During One Lung Ventilation in Pediatric Surgery.(RCT) | completed | N/A | 110 | Damascus UniversityOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT02941900 | Interest and Impact of Skin Cancer Genetic Testing | completed | — | 53 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT04918381 | CellFX Treat & Resect Low-Risk BCC Feasibility Study | completed | N/A | 30 | Pulse Biosciences, Inc.INDUSTRY | 1 | Jan 11, 2023 | clinicaltrials |
| NCT05628714 | A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma | completed | — | 222 | Maastricht University Medical CenterOTHER | 1 | Nov 29, 2022 | clinicaltrials |
| NCT03457766 | Presurgical Evaluation of Skin Cancers Using HIFU | completed | N/A | 40 | Assiut UniversityOTHER | 1 | Nov 25, 2022 | clinicaltrials |
| NCT00540566 | Optical Biopsy of Human Skin in Conjunction With Laser Treatment | completed | — | 113 | University of California, IrvineOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT02218164 | Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma | completed | Phase 2 | 8 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Oct 7, 2022 | clinicaltrials |
| NCT00470496 | Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer | completed | Phase 1 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT04116983 | DERM NMSC Validation Study | completed | — | 572 | Skin Analytics LimitedINDUSTRY | 1 | May 18, 2022 | clinicaltrials |
| NCT05315128 | Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers | completed | Phase 2 | 60 | Zagazig UniversityOTHER_GOV | 1 | Apr 7, 2022 | clinicaltrials |
| NCT03458117 | T-VEC in Non-melanoma Skin Cancer(20139157 T-VEC) | completed | Phase 1 | 26 | University of ZurichOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT00518037 | Quality of Life in Patients With Nonmelanoma Skin Cancer | completed | — | 112 | Northwestern UniversityOTHER | 1 | Dec 6, 2021 | clinicaltrials |
| NCT02751151 | Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients(PDT) | completed | N/A | 10 | Inova Health Care ServicesOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT04123678 | DERM Health Economics Study | completed | — | 700 | Skin Analytics LimitedINDUSTRY | 1 | Aug 13, 2021 | clinicaltrials |
| NCT03180528 | Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer | completed | Phase 2 | 30 | Kavita SarinOTHER | 1 | Jun 8, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Apr 2, 2025source: clinicaltrials